Gene Editing and Genotoxicity: Targeting the Off-Targets

Gene editing technologies show great promise for application to human disease as a result of rapid developments in targeting tools notably based on ZFN, TALEN, and CRISPR-Cas systems. Precise modification of a DNA sequence is now possible in mature human somatic cells including stem and progenitor cells with increasing degrees of efficiency. At the same time new technologies are required to evaluate their safety and genotoxicity before widespread clinical application can be confidently implemented. A number of methodologies have now been developed in an attempt to predict expected and unexpected modifications occurring during gene editing. This review surveys the techniques currently available as state of the art, highlighting benefits and limitations, and discusses approaches that may achieve sufficient accuracy and predictability for application in clinical settings.

[1]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[2]  Peng Qiu,et al.  COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites , 2014, Molecular therapy. Nucleic acids.

[3]  Daesik Kim,et al.  Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases. , 2019, Annual review of biochemistry.

[4]  BiascoLuca.  Integration Site Analysis in Gene Therapy Patients: Expectations and Reality. , 2017 .

[5]  Qiaobing Xu,et al.  Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents , 2017, Nature.

[6]  Wei-Ting Hwang,et al.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.

[7]  Teresa M. Przytycka,et al.  DNA Break Mapping Reveals Topoisomerase II Activity Genome-Wide , 2014, International journal of molecular sciences.

[8]  Wei Chen,et al.  Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Mazhar Adli,et al.  Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease , 2014, Nature Biotechnology.

[10]  Leslie S. Edwards,et al.  Mapping the genomic landscape of CRISPR–Cas9 cleavage , 2017, Nature Methods.

[11]  Martin J. Aryee,et al.  GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.

[12]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[13]  Adrian J. Thrasher,et al.  Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells , 2017, Science Translational Medicine.

[14]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[15]  Elif Karaca,et al.  Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. , 2014, Cell reports.

[16]  J. Sklar,et al.  Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases , 1995, Nature Genetics.

[17]  Jesse R. Dixon,et al.  Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.

[18]  David R. Liu,et al.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.

[19]  Christof von Kalle,et al.  and insertional genotoxicity Cell culture assays reveal the importance of retroviral vector design for , 2006 .

[20]  A. Nussenzweig,et al.  DNA Breaks and End Resection Measured Genome-wide by End Sequencing. , 2016, Molecular cell.

[21]  Andreas Gogol-Döring,et al.  RNA-guided retargeting of Sleeping Beauty transposition in human cells , 2020, eLife.

[22]  Jérôme Larghero,et al.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.

[23]  V. Myer,et al.  Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus , 2017, Nature Communications.

[24]  Georges Blattner,et al.  Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome , 2020, Nature Communications.

[25]  Morgan L. Maeder,et al.  Genome-editing Technologies for Gene and Cell Therapy , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  J. Durocher,et al.  Mutation detection using Surveyor nuclease. , 2004, BioTechniques.

[27]  Charles D. Yeh,et al.  Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq , 2018, Science.

[28]  Luca Biasco,et al.  Lentiviral gene therapy for X-linked chronic granulomatous disease , 2020, Nature Medicine.

[29]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[30]  Nicole M. Gaudelli,et al.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage , 2017, Nature.

[31]  J. Keith Joung,et al.  CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells , 2020, Nature Biotechnology.

[32]  Daesik Kim,et al.  Genome-wide target specificity of CRISPR RNA-guided adenine base editors , 2019, Nature Biotechnology.

[33]  Christopher Baum,et al.  A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. , 2014, The New England journal of medicine.

[34]  Ivan Merelli,et al.  Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response , 2019, Cell stem cell.

[35]  Bruce R. Conklin,et al.  CRISPR off-target detection with DISCOVER-seq , 2020, Nature Protocols.

[36]  Zeger Debyser,et al.  Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras , 2016, PloS one.

[37]  Pratima Chowdary,et al.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. , 2011, The New England journal of medicine.

[38]  Jeffrey C. Miller,et al.  An unbiased genome-wide analysis of zinc-finger nuclease specificity , 2011, Nature Biotechnology.

[39]  Jin-Soo Kim,et al.  Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases , 2014, Bioinform..

[40]  A. Zanghellini,et al.  A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells. , 2003, Nucleic acids research.

[41]  Jennifer A. Doudna,et al.  CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity , 2018, Science.

[42]  Luca Biasco.  Integration Site Analysis in Gene Therapy Patients: Expectations and Reality. , 2017, Human gene therapy.

[43]  Maximilian Haeussler,et al.  CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens , 2018, Nucleic Acids Res..

[44]  Imen Lassadi,et al.  High‐resolution profiling of γH2AX around DNA double strand breaks in the mammalian genome , 2010, The EMBO journal.

[45]  Hang Wu,et al.  Nick-seq for single-nucleotide resolution genomic maps of DNA modifications and damage , 2019, bioRxiv.

[46]  David R. Liu,et al.  Search-and-replace genome editing without double-strand breaks or donor DNA , 2019, Nature.

[47]  K. Cornetta,et al.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.

[48]  G. Cullot,et al.  CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations , 2019, Nature Communications.

[49]  Kevin T. Zhao,et al.  Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity , 2017, Science Advances.

[50]  Jin-Soo Kim,et al.  Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.

[51]  Morgan L. Maeder,et al.  UDiTaS™, a genome editing detection method for indels and genome rearrangements , 2018, BMC Genomics.

[52]  Barry L. Stoddard,et al.  The homing endonuclease I-CreI uses three metals, one of which is shared between the two active sites , 2001, Nature Structural Biology.

[53]  Chunyan Ren,et al.  Therapeutic base editing of human hematopoietic stem cells , 2020, Nature Medicine.

[54]  Daesik Kim,et al.  Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins , 2014, Genome research.

[55]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.

[56]  Christine Kinnon,et al.  Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans , 2006, Pediatrics.

[57]  Gang Bao,et al.  A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human haematopoietic stem and progenitor cells , 2018, Nature Medicine.

[58]  Howard Y. Chang,et al.  CRISPR-engineered T cells in patients with refractory cancer , 2020, Science.

[59]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[60]  Richard L. Frock,et al.  Detecting DNA double-stranded breaks in mammalian genomes by linear amplification–mediated high-throughput genome-wide translocation sequencing , 2016, Nature Protocols.

[61]  Jong-il Kim,et al.  Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells , 2015, Nature Methods.

[62]  Yilong Li,et al.  Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library , 2013, Nature Biotechnology.

[63]  Gang Wang,et al.  Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells , 2014, Nature Communications.

[64]  Andreas Reinisch,et al.  Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6 , 2017, eLife.

[65]  Nicholas A. Rossi,et al.  Inference of CRISPR Edits from Sanger Trace Data , 2019, bioRxiv.

[66]  W. F. Anderson,et al.  September 14, 1990: the beginning. , 1990, Human gene therapy.

[67]  Daesik Kim,et al.  Genome-wide target specificities of CRISPR RNA-guided programmable deaminases , 2017, Nature Biotechnology.

[68]  Clelia Di Serio,et al.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration , 2006, Nature Biotechnology.

[69]  Qiu-Xiang Cheng,et al.  CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA , 2018, Cell Research.

[70]  Michel C. Nussenzweig,et al.  Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes , 2011, Cell.

[71]  A. Bogdanove,et al.  TAL Effectors: Customizable Proteins for DNA Targeting , 2011, Science.

[72]  Daesik Kim,et al.  DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA , 2018, Genome research.

[73]  Zeger Debyser,et al.  LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[74]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[75]  Yuan Ping,et al.  Off-Targeting of Base Editors: BE3 but not ABE induces substantial off-target single nucleotide variants , 2019, Signal Transduction and Targeted Therapy.

[76]  Giuseppe Petrosino,et al.  Genome-wide Nucleotide-Resolution Mapping of DNA Replication Patterns, Single-Strand Breaks, and Lesions by GLOE-Seq , 2020, Molecular cell.

[77]  Melanie Boerries,et al.  Quantitative Evaluation of Chromosomal Rearrangements in Primary Gene-Edited Human Stem Cells by Preclinical CAST-Seq , 2020, SSRN Electronic Journal.

[78]  Jin-Soo Kim,et al.  Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9 , 2015, Molecules and cells.

[79]  David R. Liu,et al.  Analysis and minimization of cellular RNA editing by DNA adenine base editors , 2019, Science Advances.

[80]  Philippe Horvath,et al.  The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli , 2011, Nucleic acids research.

[81]  Cheng-Zhong Zhang,et al.  Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing , 2020, Nature Genetics.

[82]  Hang Wu,et al.  Nick-seq for single-nucleotide resolution genomic maps of DNA modifications and damage , 2020, Nucleic acids research.

[83]  David A. Scott,et al.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.

[84]  Dan Liu,et al.  Genome-wide profiling of adenine base editor specificity by EndoV-seq , 2019, Nature Communications.

[85]  Giacomo Cavalli,et al.  Organization and function of the 3 D genome , 2022 .

[86]  Jenny A. Greig,et al.  ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing , 2020, BMC Genomics.

[87]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.

[88]  Philipp Kapranov,et al.  Novel approach reveals genomic landscapes of single-strand DNA breaks with nucleotide resolution in human cells , 2019, Nature Communications.

[89]  Feng Zhang,et al.  Breaks Labeling in situ and sequencing (BLISS) , 2017 .

[90]  David M Weinstock,et al.  Induction of chromosomal translocations in mouse and human cells using site-specific endonucleases. , 2008, Journal of the National Cancer Institute. Monographs.

[91]  Samuel H. Sternberg,et al.  Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration , 2019, Nature.

[92]  Ruochi Zhang,et al.  CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity , 2020, Nature Biotechnology.

[93]  Luca Biasco,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome , 2013, Science.

[94]  Jacqueline Corrigan-Curay,et al.  Genome Editing Technologies: Defining a Path to Clinic: Genomic Editing: Establishing Preclinical Toxicology Standards, Bethesda, Maryland 10 June 2014. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[95]  Alessandro Aiuti,et al.  Hot spots of retroviral integration in human CD34+ hematopoietic cells. , 2007, Blood.

[96]  Richard L. Frock,et al.  Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases , 2014, Nature Biotechnology.

[97]  Giacomo Cavalli,et al.  Organization and function of the 3D genome , 2016, Nature Reviews Genetics.

[98]  Toni Cathomen,et al.  Genotoxicity in gene therapy: an account of vector integration and designer nucleases. , 2008, Current opinion in molecular therapeutics.

[99]  Hans Martin,et al.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease , 2010, Nature Medicine.

[100]  C. Dunbar,et al.  The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[101]  T. Rabbitts,et al.  Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. , 2004, The New England journal of medicine.

[102]  Daniel Capurso,et al.  DNA Repair Profiling Reve als Nonrandom Outcomes at Cas 9-Mediated Breaks Graphical Abstract Highlights , 2016 .

[103]  Alessandro Romanel,et al.  A highly specific SpCas9 variant is identified by in vivo screening in yeast , 2018, Nature Biotechnology.

[104]  Martin Kircher,et al.  Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform , 2011, Nucleic acids research.

[105]  F. Gage,et al.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[106]  George M. Church,et al.  CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing , 2014, Nucleic Acids Res..

[107]  M. Rowicka,et al.  Nucleotide-resolution DNA double-strand breaks mapping by next-generation sequencing , 2013, Nature Methods.

[108]  Yong-Sam Kim,et al.  Unbiased investigation of specificities of prime editing systems in human cells , 2020, Nucleic acids research.

[109]  Erik L. G. Wernersson,et al.  BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks , 2017, Nature Communications.

[110]  Anob M. Chakrabarti,et al.  Target-Specific Precision of CRISPR-Mediated Genome Editing , 2018, bioRxiv.

[111]  A. Bradley,et al.  Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements , 2018, Nature Biotechnology.

[112]  J. Keith Joung,et al.  731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects , 2016 .

[113]  Stefan Posch,et al.  TALENoffer: genome-wide TALEN off-target prediction , 2013, Bioinform..

[114]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[115]  Jon P. Connelly,et al.  CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing , 2019, Scientific Reports.

[116]  Adam James Waite,et al.  An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.

[117]  Jin-Soo Kim,et al.  Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq , 2016, Genome research.

[118]  Christine Kinnon,et al.  Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. , 2007, The Journal of clinical investigation.

[119]  A. Iafrate,et al.  Anchored multiplex PCR for targeted next-generation sequencing , 2014, Nature Medicine.

[120]  Yuanyuan Hou,et al.  Prime editing primarily induces undesired outcomes in mice , 2020, bioRxiv.

[121]  T. Lu,et al.  Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[122]  Matthew C. Canver,et al.  Analyzing CRISPR genome-editing experiments with CRISPResso , 2016, Nature Biotechnology.

[123]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[124]  J. Joung,et al.  CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets , 2017, Nature Methods.